Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score

被引：91
|
作者：
Lam, John S.
Seligson, David B.
Yu, Hong
Li, Ai
Eeva, Mervi
Pantuck, Allan J.
Zeng, Gang
Horvath, Steve
Belldegrun, Arie S.
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA USA
来源：
BJU INTERNATIONAL | 2006年 / 98卷 / 02期
关键词：
flap endonuclease 1; Gleason grade; prostate cancer; tissue microarray; tumour markers; EUKARYOTIC DNA-REPLICATION; CELL NUCLEAR ANTIGEN; GENE FEN1; EXPRESSION; IDENTIFICATION; OPTIMIZATION; MITOXANTRONE; EXONUCLEASE; MICROARRAYS; PREDNISONE;
D O I：
10.1111/j.1464-410X.2006.06224.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
To investigate the expression and potential clinical usefulness of structure-specific flap endonuclease 1 (FEN-1) in human primary prostate cancer using tissue microarray technology, as FEN-1 was recently identified to be overexpressed in CL1.1, the most aggressive clone generated from the hormone-refractory prostate cancer cell line CL1.
引用
收藏
页码：445 / 451
页数：7
相关论文
共 50 条
  • [41] Gleason score and survival in conservatively treated localised prostate cancer
    Berney, DM
    Fisher, G
    Cuzick, J
    Scardino, P
    Kattan, M
    Reuter, V
    Foster, CS
    MODERN PATHOLOGY, 2006, 19 : 130A - 130A
  • [42] Prostate cancer screening and Gleason score: empirical clinical practice
    Takahashi, Takeshi
    VIRCHOWS ARCHIV, 2024,
  • [43] Effect of the number of core biopsies of the prostate: On predicting Gleason score of prostate cancer
    Thickman, D
    Speers, WC
    Philpott, PJ
    Shapiro, H
    JOURNAL OF UROLOGY, 1996, 156 (01): : 110 - 113
  • [44] Prostate Specific Antigen Level and Gleason Score in Indonesian Prostate Cancer Patients
    Herawan, Muhammad Imam Al Kautsar
    Adriansjah, Ricky
    MAJALAH KEDOKTERAN BANDUNG, 2024, 56 (03): : 209 - 213
  • [45] PROSTATE CANCER Is prostatectomy for Gleason score 6 a treatment failure?
    van der Kwast, Theodorus H.
    Roobol, Monique J.
    NATURE REVIEWS UROLOGY, 2015, 12 (01) : 10 - U135
  • [46] Gleason score and survival in conservatively treated localised prostate cancer
    Berney, DM
    Fisher, G
    Cuzick, J
    Scardino, P
    Kattan, M
    Reuter, V
    Foster, C
    LABORATORY INVESTIGATION, 2006, 86 : 130A - 130A
  • [47] Gleason score, age and screening:: Modeling dedifferentiation in prostate cancer
    Draisma, Gerrit
    Postma, Renske
    Schroder, Fritz H.
    van der Kwast, Theo H.
    de Koning, Harry J.
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (10) : 2366 - 2371
  • [48] Redefining intermediate risk prostate cancer using Gleason score
    Pollard, M.
    Lavery, H. J.
    Hobbs, A. R.
    Hall, S.
    Levinson, A. W.
    Samadi, D. B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E766 - U626
  • [49] Risk stratification of Prostate cancer: How accurate is the Gleason Score?
    Heide, J.
    Siegmann, A.
    Droeber, J.
    Hinkelbein, W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 41 - 41
  • [50] The Quantitative Gleason Score Improves Prostate Cancer Risk Assessment
    Reese, Adam C.
    Cowan, Janet E.
    Brajtbord, Jonathan S.
    Harris, Catherine R.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    CANCER, 2012, 118 (24) : 6046 - 6054
12345